Pituitary Tumor AP-2α Recognizes a Cryptic Promoter in Intron 4 of Fibroblast Growth Factor Receptor 4
Open Access
- 1 May 2003
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (22) , 19597-19602
- https://doi.org/10.1074/jbc.m212432200
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The pathogenesis of pituitary tumoursNature Reviews Cancer, 2002
- Fibroblast Growth Factor Receptor 4 Is a Target for the Zinc-Finger Transcription Factor Ikaros in the PituitaryMolecular Endocrinology, 2002
- Targeted expression of a human pituitary tumor–derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesisJournal of Clinical Investigation, 2002
- Identification and Functional Characterization of the Human and Murine Fibroblast Growth Factor Receptor 4 PromotersBiochemical and Biophysical Research Communications, 2000
- Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4Oncogene, 2000
- The fibroblast growth factor receptor FGFR-4 acts as a ligand dependent modulator of erythroid cell proliferationOncogene, 1999
- AP2alpha and AP2gamma: a comparison of binding site specificity and trans-activation of the estrogen receptor promoter and single site promoter constructsNucleic Acids Research, 1999
- Genomic structure and complete sequence of the human FGFR4 geneMammalian Genome, 1998
- Differential Expression of the Fibroblast Growth Factor Receptor (FGFR) Multigene Family in Normal Human Adult TissuesJournal of Histochemistry & Cytochemistry, 1997
- bFGF and aFGF induce membrane ruffling in breast cancer cells but not in normal breast epithelial cells: FGFR-4 involvementBiochemical Journal, 1995